Targeting cytokine/chemokine receptors: A challenge for molecular nuclear medicine

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 1, 2003, Pages 149-156

  Signore, A ^a   Chianelli, M ^b   Bei, R ^c   Oyen, W ^d   Modesti, A ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Chemokines; Cytokines; Imaging; Inflammation

Indexed keywords

ALPHA CHEMOKINE; CANCER GROWTH FACTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 8; IODINE 123; MONOCYTE CHEMOTACTIC PROTEIN 1; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER; CANCER CELL; HUMAN; IMMUNOTHERAPY; INFECTION; INFLAMMATION; ISOTOPE LABELING; MEDICAL RESEARCH; METASTASIS; NUCLEAR MEDICINE; ONCOLOGY; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANIMALS; CHEMOKINES; CYTOKINES; HUMANS; ISOTOPE LABELING; MOLECULAR BIOLOGY; NEOPLASMS; NUCLEAR MEDICINE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; TUMOR MARKERS, BIOLOGICAL;

EID: 0038207046     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0941-z     Document Type: Article

References (56)

1. Signore A, Procaccini E, Annovazzi A, Chianelli M, van der Laken C, Mire-Sluis A. The developing role of cytokines for imaging inflammation and infection. Cytokine 2000; 12:1445-1454.
2. Procaccini E, Chianelli M, Pantano P, Signore A. Imaging of autoimmune diseases. Q J Nucl Med 1999; 43:100-112.
3. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/inflammation in the new millennium. Eur J Nucl Med 2001; 28:241-252.
4. Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001; 345:833-836.
5. Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol 2001; 74:3-8.
6. Fridman WH, Tartour E. Cytokines and cell regulation. Mol Aspects Med 1997; 18:1-90.
7. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 1997; 10:742-780.
8. Oppenheim J, Fujiwara H. The role of cytokines in cancer. Cytokine Growth Factor Rev 1996; 7:279-288.
9. Musiani P, Modesti A, Giovarelli M, Cavallo F, Colombo MP, Lollini PL, Forni G. Cytokines, tumor-cell death and immunogenicyty: a question of choice. Immunol Today 1997; 18:32-36.
10. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52:145-176.
11. Zlotnik A, Yoshie O. Chemokine: a new classification system and their role in immunity. Immunity 2000; 12:121-127.
12. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445.
13. Rendl J, Guthoff R, Schirbel A, Brechtelsbauer D, Schiller D, Seybold S, Schneider P, Lorenz P, Lieb W, Reiners C. Iodine123-interleukin-2 (I-123-IL-2) scintigraphy in Graves' ophthalmopathy (GO): a new approach to assess disease activity [abstract]. Endocr J 2000; 47:0-004.
14. 123I-interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity. J Pediatr Endocrinol Metab 1996; 9:139-144.
15. 123I-interleukin-2 and its response to diet. Eur J Nucl Med 2000; 27:18-24.
16. 123I-interleukin-2 scintigraphy for the in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. J Nucl Med 2000; 41:242-249.
17. 125iodine labeled interleukin-2 in the pancreas of NOD mice. J Autoimmun 2001; 17:281-287.
18. 99mTc-IL2 scintigraphy in autoimmune thyroid diseases [abstract]. Eur J Nuct Med 1998; 25:977.
19. 99mTc-IL2 scintigraphy [abstract]. Eur J Nucl Med 1998; 25:897.
20. Abbs IC, Pratt JR, Dallman MJ, Sacks SH. Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123-iodine-interleukin 2. Transpl Immunol 1993; 1:45-51.
21. 99mTc-IL2 scintigraphy in patients with cutaneous melanoma: detection of lymphocytic infiltration [abstract]. Eur J Nuct Med 1998; 25:896.
22. Barone R, Chianelli M, Nardi G, Parisella MG, Di Leve G, Mire Sluis A, Signore A. Radiolabelled interleukin-12 p40. A new radiopharmaceutical for imaging chronic TH1-mediated inflammation [abstract]. Q J Nuct Med 1998; 42 (Suppl 1):77.
23. Van der Laken CJ, Boerman OC, Oyen WJG, Van de Ven MTP, Claessens RAMJ, Van der Meer JWM, Corstens FHM. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med 1995; 22:1249-1255.
24. Van der Laken CJ, Boerman OC, Oyen WJG, Laverman P, Van de Ven MTP, Corstens FHM, Van der Meer JWM. In-vivo expression of IL-1 receptors during various experimentally induced inflammatory conditions. J Infect Dis 1998; 177:1398-1401.
25. Van der Laken CJ, Boerman OC, Oyen WJG, Van de Ven MTP, Van der Meer JWM, Corstens FHM. Imaging of infection in rabbits with radioiodinated interleukin-1 (a and b), its receptor antagonist and a chemotactic peptide. A comparative study. Eur J Nucl Med 1998; 25:347-352.
26. Van der Laken CJ, Boerman OC, Oyen WJG, Van de Ven MTP, Chizzonite R, Corstens FHM, Van der Meer JWM. Preferential localization of systemically administered radiolabelled interleukin-1alpha in experimental inflammation in mice by binding to the type II receptor. J Clin Invest 1997; 100: 2970-2976.
27. Van der Laken CJ, Boerman OC, Oyen WJG, Van der Ven MTP, Claessens RAMJ, Van der Meer JWM, Corstens FHM. Different behavior of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection. Eur J Nucl Med 1996; 23:1531-1535.
28. Van der Laken CJ, Barrera P, Boerman OC, Oyen WJG, Van der Ven MTP, Van der Meer JWM, Van de Putte LBA, Corstens FHM. Radiolabelled interleukin-1 receptor antagonist targets to inflamed joints in patients with active rheumatoid arthritis. A report of preliminary results [abstract]. Eur J Nucl Med 1998; 25:897.
29. Barrera P, van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van Lent PL, van de Putte LB, Corstens FH. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology (Oxf) 2000; 39:870-874.
30. 125I-TGF-beta1 to fenestrated endothelium in bone and anastomosing capillary networks in enamel organ suggests a role for TGF-beta1 in angiogenesis. Calcif Tissue Int 2001; 68:304-315.
31. 123I-labelled epidermal growth factor. Lancet 1991; 337:395-396.
32. 111In for imaging human breast cancer. J Nucl Med 2000; 41:903-911.
33. 125I-EGF after topical administration to skin wounds. Biopharm Drug Dispos 2002; 23:67-76.
34. Blankenberg FG, Tait JF, Blankenberg TA, Post AM, Strauss HW. Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med 2001; 28:1384-1393.
35. Van der Laken CJ, Boerman OC, Oyen WJG, Van de Ven MPT, Laverman P, Van der Meer JWM, Corstens FHM. Targeting inflammation with radiolabeled interleukin-1 and other cytokines in various mouse models [abstract]. Nucl Med Commun 1997; 18:478.
36. Virgolini I, Kurtaran A, Leimer M, Smith-Jones P, Agis H, Angelberger P, Kletter K, Valent P, Linkesh W, Eichlacher HG. Inhalation scintigraphy with iodine-123-labeled interferon-gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers. J Nucl Med 1997; 38:1475-1481.
37. 99mTc-labeled interleukin-8. J Nucl Med 2001; 42:117-123.
38. van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van der Meer JW, Corstens FH. Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours. J Nucl Med 2000; 41:463-469.
39. 99mTc-interleukin-8 in rabbits. J Nucl Med 2001; 42:917-923.
40. Rennen HJ, van Eerd JE, Oyen WJ, Corstens FH, Edwards DS, Boerman OC. Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection. Bioconjug Chem 2002; 13:370-377.
41. 99mTc-interleukin-8 for imaging acute osteomyelitis. J Nucl Med 2001; 42:1257-1264.
42. 131I-labeled recombinant human interleukin-8. J Nucl Med 2001; 42:1656-1659.
43. Hay RV, Skinner RS, Newman OC, Kunkel SL, Lyle LR, Shapiro B, Gross MD. Scintigraphy of acute inflammatory lesions in rats with radiolabelled recombinant human interleukin-8. Nucl Med Commun 1997; 18:367-378.
44. Chianelli M, Signore A, Ferretti E, Valente L, Bartolini A, D'Orrico G, Multari G, Pozzilli P. Detection of IL4R on human carcinomas by phycoerythrin conjugated IL4. Eur J Basic Appl Histochem 1997; 35:272.
45. Taichman RS, McCaueley LK, Taichman NS. Use of the SDF1/CXCR4 pathway in prostate cancer cancer metastasis to bone. Blood 2000; 96:571a.
46. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP, Ben-Baruch A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167:4747-4757.
47. Moore MAS. The role of chemoattraction in cancer metastases. Biossays 2001; 23:674-676.
48. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 2001; 61:4961-4965.
49. Sanz-Rodriguez F, Hidalgo A, Teixido J. Chemokine stromal cell-derived factor-1 modulates VLA4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VECAM1. Blood 2001; 97:346-351.
50. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell derived factor-1. Eur J Haematol 2000; 64:323-333.
51. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M. Expression of stromal cell-derived factor-1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000; 6:3530-3535.
52. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001; 7:3298-3304.
53. Muller A, Homey B, Soto H, Ge N, Catron D, Buchmann ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui M, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
54. 125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol 2000; 110:151-160.
55. Seidel MG, Freissmuth M, Pehamberger H, Micksche M. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 382-389.
56. Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient. Melanoma Res 1997; 7 (Suppl 2):S7-S17.